Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment

Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer in the world. According to Barcelona Clinic Liver Cancer modified criteria, patients with early stage disease are candidate to radiofrequency ablation (RFA), while patients with intermediate stage HCC are usually treated by tran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Ranieri, Girolamo, Marech, Ilaria, Lorusso, Vito, Goffredo, Veronica, Paradiso, Angelo, Ribatti, Domenico, Gadaleta, Cosmo Damiano
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2014
Assuntos:
Minireviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923023/
https://ncbi.nlm.nih.gov/pubmed/24574717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i2.486
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados